Serum C peptide level and renal function in diabetes mellitus

Indian Journal of Nephrology

Volumn 20, Issue 1, 2010, Pages 25-28

  Chowta, M N ^a   Adhikari, P M ^a   Chowta, N K ^a   Shenoy, A K ^a   D'Souza, S ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

C peptide; Creatinine clearance; Microalbuminuria

Indexed keywords

ALBUMIN; C PEPTIDE; HEMOGLOBIN A1C;

ADULT; ALBUMINURIA; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET; FEMALE; HUMAN; KIDNEY CLEARANCE; KIDNEY DISEASE; KIDNEY FUNCTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; RISK ASSESSMENT; UREA NITROGEN BLOOD LEVEL;

EID: 77953453846     PISSN: 09714065     EISSN: 19983662     Source Type: Journal    
DOI: 10.4103/0971-4065.62093     Document Type: Article

References (15)

1. Kitabchi A. Proinsulin and C-peptide. Metabolism 1977;26:547-587
2. Regeur L, Faber OK, Binder C. Plasma C-peptide in uraemic patients. Scand J Clin Lab Invest 1978;38:771-775 (Pubitemid 9085053)
3. Wahren J, Ekberg K, Johansson J, Henriksson M, Pramanik A, Johansson BL, et al. Role of C-peptide in human physiology. Am J Physiol Endocrinol Metab 2000;278:59-68.
4. Rigler R, Pramanik A, Jonasson P, Kratz G, Jansson O, Nygren PÅ, et al. Specific binding of proinsulin C-peptide to human cell membranes. Proc Natl Acad Sci USA 1999;96:1318-1323
5. Sjöquist M, Huang W, Johansson BL. Effects of C-peptide on renal function at the early stage of experimental diabetes. Kidney Int 1998;54:758-764 (Pubitemid 28397393)
6. Johansson BL, Kernell A, Sjöberg S, Wahren J. Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J Clin Endocrinol Metab 1993;77:976-981 (Pubitemid 23301473)
7. Hagen C, Faber O, Binder C, Alberti K. Lack of metabolic effect of C-peptide in normal subjects and juvenile diabetic patients. Acta Endocrinologica 1977;85:29. (Pubitemid 8132152)
8. Hoogwerf B, Bantle J, Gaenslen H, Greenberg B, Senske B, Francis R, et al. Infusion of synthetic human C-peptide does not affect plasma glucose, serum insulin, or plasma glucagon in healthy subjects. Metabolism 1986;35:122-125 (Pubitemid 16160927)
9. Mogensen C, Andersen M. Increased kidney size and glomerular filtration rate in untreated juvenile diabetes: Normalisation by insulin treatment. Diabetologia 1975;11:221-224
10. Sandahl-Christiansen J, Frandsen M, Parving H. The effect of intravenous insulin infusion on kidney function in insulin-dependent diabetes mellitus. Diabetologia 1981;20:199-204. (Pubitemid 11134127)
11. Friedman E, Sheih SD, Hirsch S, Boshell B. No supranormal glomerular filtration (GFR) in type II (non-insulin-dependent) diabetes. Am Soc Nephrol 1981;14:102A.
12. Schmitz A, Gundersen H, Österby R. Glomerular morphology by light microscopy in non-insulin-dependent diabetes mellitus. Diabetes 1988;37:38-43.
13. Djemli A, Gallice P, Coste T, Jannot M, Dufayet D, Raccah D, et al. Ex vivo and in vitro effects of insulin and C-peptide on Na/K ATPase activity in red blood cell membranes of type 1 diabetic patients. Diabetologia 1999;42:A154.
14. Kunt T, Forst T, Closs E, Wallerath U, Förstermann R, Lehmann R, et al. Activation of endothelial nitric oxide synthase (eNOS) by C-peptide. Diabetologia 1998;41:A176.
15. Johansson BL, Borg K, Fernqvist-Forbes E, Kernell A, Odergren T, Wahren J. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type I diabetes: A three-month study. Diabetic Med 2000;17:181-189 (Pubitemid 30212289)